However, depletion of CD8+ T cells (Asparaginase + anti-PD-L1 + anti-CD8 group) significantly diminished the anti-tumor efficacy of the combination therapy, resulting in tumor growth rates significantly faster than the Asparaginase + anti-PD-L1 group. This evidence concerns the gene CD8A and neoplasm.